We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
964
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.33%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PASG icon
2826
Passage Bio
PASG
$15.4M
$438K ﹤0.01%
9,256
-689
-7% -$32.2K
KEN icon
2827
Kenon Holdings
KEN
$3.68B
$437K ﹤0.01%
10,935
+1,990
+22% +$110K
PKOH icon
2828
Park-Ohio Holdings
PKOH
$565M
$437K ﹤0.01%
+27,491
New +$386K
TSAT icon
2829
Telesat
TSAT
$580M
$437K ﹤0.01%
+39,100
New +$551K
AREC icon
2830
American Resources Corp
AREC
$186M
$436K ﹤0.01%
301,291
+222,473
+282% +$396K
BARK.WS
2831
CALL
DELISTED
BARK Inc Warrants
BARK.WS
$435K ﹤0.01%
340,000
CDMO
2832
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$435K ﹤0.01%
28,505
+8,023
+39% +$119K
DMTK
2833
DELISTED
DermTech, Inc. Common Stock
DMTK
$434K ﹤0.01%
78,277
-1,024,043
-93% -$8.38M
AAT
2834
American Assets Trust
AAT
$1.5B
$433K ﹤0.01%
14,569
+615
+4% +$20.6K
RPTX
2835
DELISTED
Repare Therapeutics
RPTX
$433K ﹤0.01%
+30,900
New +$364K
KFRC icon
2836
Kforce
KFRC
$1.02B
$432K ﹤0.01%
+7,044
New +$481K
MYPS icon
2837
PLAYSTUDIOS Inc
MYPS
$84.2M
$431K ﹤0.01%
100,600
+332
+0.3% +$1.8K
SLF icon
2838
Sun Life Financial
SLF
$45.8B
$430K ﹤0.01%
+9,400
New +$468K
MBT
2839
DELISTED
Mobile TeleSystems Public Joint Stock Company American Depositary Shares (Each representing 2 Shares
MBT
$430K ﹤0.01%
214,327
EPU icon
2840
iShares MSCI Peru and Global Exposure ETF
EPU
$534M
$429K ﹤0.01%
+16,815
New +$521K
TKC icon
2841
Turkcell
TKC
$4.75B
$429K ﹤0.01%
+171,344
New +$554K
YI
2842
111 Inc
YI
$429K ﹤0.01%
20,877
+1,892
+10% +$37.8K
NTP
2843
DELISTED
Nam Tai Property Inc.
NTP
$428K ﹤0.01%
124,137
+18,869
+18% +$111K
BIOX icon
2844
Bioceres Crop Solutions
BIOX
$21.1M
$427K ﹤0.01%
31,148
+8,088
+35% +$107K
CBAT icon
2845
CBAK Energy Technology Ltd
CBAT
$46.1M
$427K ﹤0.01%
398,359
+90,548
+29% +$105K
MIDD icon
2846
Middleby
MIDD
$6.14B
$426K ﹤0.01%
3,400
-16,267
-83% -$2.35M
AGBAW
2847
CALL
DELISTED
AGBA Acquisition Ltd Warrant
AGBAW
$426K ﹤0.01%
37,464
SPNE
2848
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$424K ﹤0.01%
+75,044
New +$654K
FIS icon
2849
Fidelity National Information Services
FIS
$22B
$423K ﹤0.01%
4,600
-46,999
-91% -$4.67M
SLAI
2850
DELISTED
SOLAI Ltd ADS
SLAI
$422K ﹤0.01%
9,746
+5,542
+132% +$693K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 964 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.